Answers are grounded in this paper and cite their sources.
Based on randomized, placebo-controlled trials (RCTs) performed in Crohn’s disease, methotrexate has been used primarily for patients failing thiopurines but also for ulcerative colitis under the assumption that methotrexate would be equally effective. First recently, RCTs in ulcerative colitis have been published, and this Editorial aim to provide the latest evidence of the use of methotrexate in inflammatory bowel disease (IBD). Methotrexate is an inexpensive, well-characterized folic acid antagonist that was originally introduced in the 1940s for the treatment of various malignant disorders. Years later this drug was discovered to have anti-inflammatory properties in lower dosages by reducing cell proliferation, inducing proapoptotic properties (especially on T cells), raising antiinflammatory endogenous adenosine concentrations, and altering cytokine production, ultimately resulting in broad immunosuppression [1–3]. For decades, orally administered methotrexate has been the mainstay of the treatment of rheumatoid arthritis [3]. Since the late 1980s methotrexate was introduced for the management of IBD [4], and in the mid-1990s, it was demonstrated that parenteral, but not oral, methotrexate was efficacious for Crohn’s disease (Figure 1). In this context, pharmacokinetic studies have revealed a substantial influence over tissue delivery of the drug [5]. Thus, a highly variable and unpredictable bioavailability has been shown in oral administration [6], whereas parenteral dosing results in a more consistent and complete absorption with a bioavailability of 87% of that of intravenous dosing [5,7]. Moreover, because similar bioavailability has been demonstrated between subcutaneous and intramuscular administration [7], subcutaneous administration is traditionally used in IBD as this is easier and less painful.
No takes yet. Share an insight, caveat, or question.
Nielsen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: